Sequenom Company Profile (NASDAQ:SQNM)

Analyst Ratings

Consensus Ratings for Sequenom (NASDAQ:SQNM) (?)
Ratings Breakdown: 5 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.31 (44.15% downside)

Analysts' Ratings History for Sequenom (NASDAQ:SQNM)
Show:
DateFirmActionRatingPrice TargetActions
7/20/2016Jefferies GroupReiterated RatingHold$1.50 -> $0.75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2016William BlairReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016Piper Jaffray Cos.Reiterated RatingHold$2.10View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016Ladenburg ThalmannUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/25/2015WedbushReiterated RatingNeutral$1.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Oppenheimer Holdings Inc.Reiterated RatingOutperform -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2014Maxim GroupBoost Price TargetBuy$6.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Sequenom (NASDAQ:SQNM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016Q216$28.65 millionN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2016Q116($0.10)($0.11)$27.85 million$27.57 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/2/2016Q415($0.10)($0.10)$29.35 million$27.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.09)($0.08)$31.35 million$29.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215($0.05)($0.08)$35.74 million$32.77 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115($0.03)$0.12$38.60 million$37.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2015Q414($0.05)$0.14$41.94 million$36.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314($0.09)($0.05)$42.80 million$37.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214($0.10)($0.07)$47.80 million$39.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114($0.14)($0.13)$46.06 million$46.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413($0.16)($0.16)$47.05 million$45.13 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.22)($0.24)$40.56 million$43.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2013Q2 2013($0.22)($0.27)$46.25 million$24.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013($0.23)($0.26)$38.29 million$38.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/7/2013Q4 2012($0.22)($0.29)$32.02 million$33.67 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312($0.23)($0.26)$22.91 million$22.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012($0.21)($0.26)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2012($0.19)($0.22)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/7/2012($0.18)($0.22)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011($0.19)($0.19)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011($0.17)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011($0.19)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2011($0.21)($0.27)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sequenom (NASDAQ:SQNM)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.11)($0.09)($0.10)
Q2 20161($0.10)($0.10)($0.10)
Q3 20161($0.06)($0.06)($0.06)
Q4 20162($0.09)($0.05)($0.07)
Q1 20171($0.04)($0.04)($0.04)
Q2 20171($0.04)($0.04)($0.04)
Q3 20171($0.03)($0.03)($0.03)
Q4 20171($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Sequenom (NASDAQ:SQNM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sequenom (NASDAQ:SQNM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/10/2016Carolyn BeaverCFOBuy30,000$1.10$33,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Carolyn BeaverCFOBuy10,000$1.10$11,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Jeffrey D LintonSVPBuy5,000$1.10$5,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2016Den Boom Dirk VanCEOBuy40,000$1.09$43,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2016Daniel S Md GrosuCMOBuy30,000$1.11$33,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Den Boom Dirk VanCEOBuy30,000$1.13$33,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Jeffrey D LintonSVPBuy10,000$1.15$11,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Camber Capital Management LlcMajor ShareholderBuy665,435$1.62$1,078,004.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015Camber Capital Management LlcMajor ShareholderBuy468,000$1.30$608,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015Camber Capital Management LlcMajor ShareholderBuy20,000$1.41$28,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/14/2015Camber Capital Management LlcMajor ShareholderBuy448,000$1.30$582,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2015Camber Capital Management LlcMajor ShareholderBuy791,565$1.30$1,029,034.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2015Camber Capital Management LlcMajor ShareholderBuy1,650,090$1.96$3,234,176.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015William J WelchCEOBuy10,000$3.65$36,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Carolyn BeaverCFOBuy10,000$3.60$36,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2015Jeffrey D LintonSVPBuy10,000$3.64$36,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/29/2012Goldman Myla LaiDirectorBuy4,000$4.59$18,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2012John A FazioDirectorBuy2,000$4.45$8,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2012Charles P SlacikDirectorBuy5,000$3.24$16,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2012John A FazioDirectorBuy2,000$3.33$6,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Sequenom (NASDAQ:SQNM)
DateHeadline
07/28/16 09:50 AMSequenom Inc. (SQNM) Jumps 176.24% on July 27 - Equities.com
07/28/16 09:50 AMAnalysts watching two Stocks: Sequenom, Inc. (NASDAQ:SQNM) , Eli Lilly and Company (NYSE:LLY) - Street Updates
07/28/16 09:50 AMSequenom, Inc.: SQNM Stock Soars on LabCorp Bid - Investorplace.com
07/28/16 06:28 AMSequenom Announces Cancellation of Second Quarter 2016 Results Conference Call - [at noodls] - SAN DIEGO, July 28, 2016/PRNewswire / -- Sequenom, Inc., (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced ...
07/27/16 09:01 PMBenzinga's M&A Chatter for Wednesday July 27, 2016 - The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday July 27, 2016:   Sequenom Being Acquired by Lab Corp for $2.40/Share in Cash The Deal: Laboratory Corporation of America Holdings (NYSE: LH) and Sequenom, Inc. (NASDAQ: SQNM) announced Wednesday, that they have entered into a definitive agreement aunder which LabCorp would acquire all of the outstanding shares of Sequenom in a cash tender offer for $2.40 per share, for an equity value of $302 million. The closing of the acquisition is expected by ...Full story available on Benzinga.com
07/27/16 06:59 PMLabCorp acquiring Sequenom for $371M
07/27/16 03:09 PMSEQUENOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights of Secur -
07/27/16 02:45 PMMid-Afternoon Market Update: Crude Oil Down 2.5%; Sequenom Shares Spike Higher -   Toward the end of trading Wednesday, the Dow traded up 0.12 percent to 18,495.63 while the NASDAQ gained 0.49 percent to 5,135.15. However, the S&P fell 0.09 percent to 2,167.15. Leading and Lagging Sectors On Wednesday, technology shares climbed by 0.78 percent. Top gainers in the sector included Unisys Corporation (NYSE: UIS) and LogMeIn Inc (NASDAQ: LOGM). In trading on Wednesday, non-cyclical consumer goods & services shares fell by 0.87 percent. Meanwhile, top losers in the sector included Strayer Education Inc (NASDAQ: STRA), down 8 percent, and SUPERVALU INC. (NYSE: SVU), down 13 percent. Top Headline Apple Inc. (NASDAQ: AAPL) reported stronger-than-expected results for its fiscal third quarter on Tuesday. The company reported earnings of $7.8 billion or $1.42 per share, which compares to Wall Street consensus EPS estimates of $1.38. The high estimate was $1.47 with a low estimate of $1.23. This represents a decline of 27 percent from the $1.85 that Apple reported in last year's third-quarter. The company reported quarterly revenue of $42.36 billion, ...Full story available on Benzinga.com
07/27/16 12:27 PMSequenom, Inc.: SQNM Stock Soars on LabCorp Bid - InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips Sequenom (SQNM) stock holders just had their best day in years as LabCorp (LH) acquires the company for its extensive women's health testing suite. The post Sequenom, Inc.: SQNM Stock Soars on LabCorp Bid appeared first on InvestorPlace.
07/27/16 09:51 AMSEQUENOM, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout - [Business Wire] - Rigrodsky & Long, P.A.:
07/27/16 09:40 AMWhy Exact Sciences Corporation's Q2 Worries Me
07/27/16 09:40 AMLabCorp Raises 2016 Adj. EPS Guidance; To Acquire Sequenom For $2.40/shr
07/27/16 09:40 AMLaboratory of America : LabCorp Announces Agreement To Acquire Sequenom
07/27/16 09:40 AMLabCorp Announces Agreement to Acquire Sequenom
07/27/16 09:40 AMSEQUENOM (SQNM) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and …
07/27/16 08:56 AMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation into Whether the Sale of Sequenom Inc. to Laboratory Corporation of America Holdings for $2.40 Per Share is Fair to Shareholders - SQNM - [Accesswire] - NEW YORK, NY / ACCESSWIRE / July 27, 2016 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Sequenom Inc. ("Sequenom") (NASDAQ: SQNM) ...
07/27/16 08:14 AM[$$] Laboratory Corp Revenue and Profit Rise -
07/27/16 08:09 AMBRIEF-Labcorp to acquire Sequenom - July 27 (Reuters) - Laboratory Corporation Of America Holdings
07/27/16 07:46 AMSequenom up 183% premarket on LabCorp buy -
07/27/16 06:43 AMDiagnostics company LabCorp to buy smaller rival Sequenom - July 27 (Reuters) - Laboratory Corporation of America Holdings said it would buy Sequenom Inc, a maker of non-invasive prenatal tests for reproductive health, for about $371 million, including debt.
07/25/16 12:44 PMETF’s with exposure to Sequenom, Inc. : July 25, 2016 -
07/23/16 05:55 PMIs $1.9 Price Target Attainable For Sequenom, Inc. (NASDAQ:SQNM)? - Investor Newswire
07/22/16 07:30 AMSequenom Schedules Second Quarter Results Conference Call for August 3, 2016 - [PR Newswire] - SAN DIEGO, July 22, 2016 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today ...
07/19/16 07:32 AMSequenom, Inc. (NASDAQ:SQNM) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/17/16 05:54 PMSequenom, Inc. (NASDAQ:SQNM) Broker Price Targets For The Coming Week - Fiscal Standard
07/15/16 05:31 PMSequenom Inc. (SQNM) Drops 7.23% on July 13 - Equities.com
07/14/16 10:09 AMHC Stocks News Bulletin: Sequenom, Inc. (NASDAQ:SQNM), Idera Pharmaceuticals Inc (NASDAQ:IDRA) - share market updates (press release)
07/14/16 10:09 AMWill Sequenom, Inc. (NASDAQ:SQNM) Surprise Analysts? - Investor Newswire
07/14/16 10:09 AMBroker Outlook For Sequenom, Inc. (NASDAQ:SQNM) - Fiscal Standard
07/12/16 10:54 AMTrading Performance and Target Watch for Sequenom, Inc. (NASDAQ:SQNM) - Press Telegraph
07/10/16 05:45 PMNext Weeks Broker Price Targets For Sequenom, Inc. (NASDAQ:SQNM) - Fiscal Standard
07/10/16 10:30 AMBrokers Issue Average Price Target Of 3.02 On Sequenom, Inc. (NASDAQ:SQNM) - Fiscal Standard
07/10/16 10:30 AMIs $1.9 Within Reach For Sequenom, Inc. (NASDAQ:SQNM)? - Investor Newswire
07/09/16 09:35 AMSequenom Inc. (SQNM) Hits New 52-week Low During July 07 Session - Equities.com
07/07/16 06:39 PMSequenom Inc. (SQNM) Hits New 52-week Low During July 05 Session - Equities.com
07/07/16 06:39 PMSequenom Inc. (NASDAQ:SQNM) Fundamental Star Rating Report - CML News
07/07/16 06:39 PMSequenom Inc. (SQNM) Jumps 5.7% on July 07 - Equities.com
07/07/16 09:18 AMSequenom Labs Announces Significant Enhancement To MaterniT GENOME
07/07/16 07:41 AMSequenom Laboratories™ Announces Significant Enhancement to MaterniT® GENOME and Will Present New Data at the 20th International Conference on Prenatal Diagnosis and Therapy - [at noodls] - 30% of MaterniT® GENOME positive findings could be detected only with genome-wide testing SAN DIEGO, July 7, 2016/PRNewswire / -- Sequenom, Inc., (NASDAQ: SQNM), a life sciences company committed to enabling ...
07/06/16 06:58 PMStock Rating Watch and Earnings Insight for Sequenom, Inc. (NASDAQ:SQNM) - Press Telegraph
07/06/16 06:58 PMInsiders Increasing Positions in: Sequenom Inc. (NASDAQ:SQNM) - Press Telegraph
07/05/16 10:40 AMBiotech New Lows: Sequenom Inc. (NASDAQ:SQNM), Protalix BioTherapeutics, Inc. (NYSEMKT:PLX), Bio Blast ... - KC Register
07/05/16 10:40 AMLast Analysts Rating Review: Sequenom, Inc. (NASDAQ:SQNM) , Chimerix, Inc. (NASDAQ:CMRX) - Street Updates
07/02/16 06:02 PMSequenom, Inc. (NASDAQ:SQNM) Expected to Reach Highs Of $1.9 - Investor Newswire
07/01/16 09:16 AMWatch List for Biotechnology Equities -- Genocea Biosciences, BioDelivery Sciences Intl., Sequenom, and INSYS Therapeutics
06/30/16 03:06 PMETF’s with exposure to Sequenom, Inc. : June 30, 2016 -
06/29/16 09:17 AMAnalysts Rating updates about two Stocks: Sequenom, Inc. (NASDAQ:SQNM) , Catalyst Pharmaceuticals, Inc ... - Street Updates
06/29/16 09:17 AMShare Update and Earnings Review for Sequenom, Inc. (NASDAQ:SQNM) - Press Telegraph
06/28/16 10:51 AMAnalyst Consideration on this Stock: Sequenom Inc. (NASDAQ:SQNM) - News Oracle
06/28/16 10:51 AMWilliam Blair Comments on Sequenom, Inc. (SQNM) Following Supreme Court Patent Ruling - Smarter Analyst

Social

About Sequenom

Sequenom logoSequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company's diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories' test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: SQNM
  • CUSIP: 81733740
Key Metrics:
  • Previous Close: $2.35
  • 50 Day Moving Average: $1.02
  • 200 Day Moving Average: $1.28
  • P/E Ratio: N/A
  • P/E Growth: -0.28
  • Market Cap: $281.35M
  • Beta: 0.67
  • Current Year EPS Consensus Estimate: $-0.33 EPS
  • Next Year EPS Consensus Estimate: $-0.17 EPS
Additional Links:
Sequenom (NASDAQ:SQNM) Chart for Thursday, July, 28, 2016